Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 31 | Sun, 8/4/2013, 2:00 PM - 3:50 PM | CC-512g | |
| Methodology for Early-Stage Oncology Trials — Contributed Papers | |||
| Biopharmaceutical Section , Biometrics Section , Korean International Statistical Society | |||
| Chair(s): Chunyan Cai, UT Health Science Center at Houston | |||
| 2:05 PM | Evaluating Probability of Success in Oncology Drug Development — Di Li, Eisai Inc | ||
| 2:20 PM | Bivariate Continual Reassessment Method (BCRM) Applied to Oncology Dose Escalation Study — Yinghua (Grace) Zhang, GSK ; Jie Ding, GSK | ||
| 2:35 PM | An 'Early-Go' Design for Single-Arm, Two-Stage, Phase II Clinical Trials — William E. Brady, Roswell Park Cancer Institute ; Gregory Wilding, Roswell Park Cancer Institute | ||
| 2:50 PM | Probability-Guided 3+3 Design in Phase I Dose-Escalation Study — Yung-Seop Lee, Dongguk Univ. ; Jung Wook Park, Astellas Pharma Global Development, Inc. | ||
| 3:05 PM | Enrollment and Stopping Rules for Managing Toxicity in Phase II Oncology Trials with Delayed Outcome — Guochen Song, Quintiles ; Anastasia Ivanova, Department of Biostatistics, UNC Chapel Hill | ||
| 3:20 PM | Using the Facts Recommender in Oncology Dose Escalation Trials: A Comparison of Dose Escalation Decisions Suggested by the Recommender with Actual Decisions Made by Project Teams — Sharon Murray, GlaxoSmithKline ; Tom Parke, Tessella plc ; Allison Florance, GlaxoSmithKline ; Alun Bedding, GlaxoSmithKline | ||
| 3:35 PM | Alternative Designs for Phase II Clinical Trials When Attained Sample Sizes Are Different from Planned Sample Sizes — Myron Chang, University of Florida | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.